We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+13.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.37B
AUM Growth
+$131M
Cap. Flow
-$20.9M
Cap. Flow %
-1.53%
Top 10 Hldgs %
25.94%
Holding
128
New
8
Increased
15
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$19.9M
2
CAG icon
Conagra Brands
CAG
+$19.5M
3
NXPI icon
NXP Semiconductors
NXPI
+$19.1M
4
MDT icon
Medtronic
MDT
+$19.1M
5
CVS icon
CVS Health
CVS
+$15.9M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$24.6M
2
AM
ANTERO MIDSTREAM PARTNERS LP
AM
+$17.8M
3
GILD icon
Gilead Sciences
GILD
+$16.6M
4
LVS icon
Las Vegas Sands
LVS
+$15.3M
5
BA icon
Boeing
BA
+$13.5M

Sector Composition

Rank Sector Weight
1 Energy 15.58%
2 Technology 12.95%
3 Financials 12.51%
4 Healthcare 12.33%
5 Consumer Staples 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIMC
126
DELISTED
Altra Industrial Motion Corp
AIMC
-77
Closed -$2K
UMPQ
127
DELISTED
Umpqua Holdings Corp
UMPQ
-2,800
Closed -$45K
AM
128
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
-831,740
Closed -$17.8M

Similar funds

Payden & Rygel's Q1 2019 Portfolio in Review

As of Q1 2019, Payden & Rygel held 128 positions worth $1.37B, up 11% from $1.24B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel's Q1 2019 filing shows 8 new, 15 increased, 34 reduced and 9 closed positions. Its largest new stake was Williams Companies: 741,800 shares worth $21.3M. The largest sale was Amgen, an estimated $24.6M.

By sector, the portfolio is most concentrated in Energy at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • Payden & Rygel's largest Q1 2019 buy was Williams Companies: 741,800 shares worth $21.3M.
  • Payden & Rygel added most to AT&T in Q1 2019, an estimated $13.4M increase.
  • Payden & Rygel's biggest Q1 2019 reduction was Amgen, cutting an estimated $24.6M.
  • Payden & Rygel fully exited ANTERO MIDSTREAM PARTNERS LP in Q1 2019, selling an estimated $17.8M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.37B portfolio in Q1 2019.
  • Payden & Rygel opened 8 new positions and closed 9 in Q1 2019.
  • Payden & Rygel's portfolio value rose 11% quarter-over-quarter to $1.37B.

Based on Payden & Rygel's 13F filing for Q1 2019, filed 8 May 2019.